GlassScriptPhysician profile
Peter J Riznyk
NPI 1730168667
$3,141.92
in general payments reported to CMS, 2019-2025
16 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Sports Medicine (Podiatrist) provider received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $602 · 2021: $790 · 2022: $359 · 2023: $248 · 2024: $105 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $479.69 | 2019-2021 | |
| Stryker Corporation | $396.00 | 2019-2023 | Anchorage |
| Treace Medical Concepts, INC. | $270.70 | 2020-2021 | |
| Amgen INC. | $249.98 | 2025 | Krystexxa |
| Smith+Nephew, INC. | $247.38 | 2019-2020 | |
| Horizon Therapeutics Plc | $222.88 | 2020-2023 | Krystexxa |
| Prodigy Surgical Distribution, INC. | $178.88 | 2025 | |
| Orthofix Medical, INC. | $169.47 | 2021 | |
| Paratek Pharmaceuticals, INC. | $124.99 | 2020 | |
| Baudax Bio INC. | $124.99 | 2022 | |
| Misonix INC | $124.00 | 2021 | |
| Lifenet Health | $123.53 | 2025 | Theragenesis Wound Matrix |
| Abbott Laboratories | $117.42 | 2023 | Proclaim, Octrode |
| Innovation Technologies INC | $113.53 | 2021 | |
| Biopoly LLC | $105.00 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $93.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Riznyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.